JULIANA PEREZ BOTERO MD
Prescription History 1396023321
Internal Medicine - Hematology & Oncology in Rochester, MN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JULIANA PEREZ BOTERO MD, an active Hematology & Oncology specialist practicing in Rochester, MN. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 131 documented patient claims. Among these therapy options, the most frequently utilized medication is Xarelto, which accounts for 39 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MN PrescribersVs. MN Avg |
|---|---|---|---|
| XareltoRivaroxaban | 39 | $1,089.02 | ≈ Typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 39 Medicare prescriptions for Xarelto, about the same volume as the typical Minnesota prescriber of this medication (34). Medicare paid an average of $1,089.02 per fill, versus $960.12 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 76 30-Day Fills standardized to 30-day supplies 2,255 Days of Medication total across all patients in 2023 | |||
| EliquisApixaban | 37 | $1,088.28 | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 37 Medicare prescriptions for Eliquis, about 70% of the volume of the typical Minnesota prescriber of this medication (53). Medicare paid an average of $1,088.28 per fill, versus $877.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 69.3 30-Day Fills standardized to 30-day supplies 2,070 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 23 | $38.00 | ▼ Less than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 23 Medicare prescriptions for Hydroxyurea, about 68% of the volume of the typical Minnesota prescriber of this medication (34). Medicare paid an average of $38.00 per fill, versus $33.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 67.8 30-Day Fills standardized to 30-day supplies 2,035 Days of Medication total across all patients in 2023 | |||
| Enoxaparin Sodium | 20 | $279.02 | ≈ Typical |
About Enoxaparin Sodium: Enoxaparin is used to prevent and treat harmful blood clots. Show more ▾ This helps to reduce the risk of a stroke or heart attack. This medication helps keep your blood flowing smoothly by lowering the activity of clotting proteins in the blood. Enoxaparin is an anticoagulant, also known as a blood thinner. It is a type of heparin. Conditions which increase your risk of developing blood clots include certain types of surgeries (such as knee/hip replacement, abdominal), long periods of being immobile, certain types of heart attack, and a specific type of chest pain called unstable angina. For some medical conditions, enoxaparin may be used in combination with other blood thinners. In 2023, this provider wrote 20 Medicare prescriptions for Enoxaparin Sodium, about the same volume as the typical Minnesota prescriber of this medication (18). Medicare paid an average of $279.02 per fill, versus $184.49 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 505 Days of Medication total across all patients in 2023 | |||
| NucalaMepolizumab | 12 | $11,288.25 | ≈ Typical |
About Nucala: This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab is also used to treat certain other immune system disorders (chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome). This medication works by decreasing a certain type of white blood cell (eosinophils). This effect helps reduce swelling (inflammation) of the airways to make breathing easier. It may also help reduce the size of nasal polyps, and lessen symptoms such as runny/stuffy nose, mucus in the throat, loss of smell, facial pain, and tiredness. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 12 Medicare prescriptions for Nucala, about 86% of the volume of the typical Minnesota prescriber of this medication (14). Medicare paid an average of $11,288.25 per fill, versus $4,879.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for JULIANA PEREZ BOTERO MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Rochester, MN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
